drugset
drugset / Trial / NCT02277067

Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S.

NCT02277067 ↗

Phase 4 Unknown 200 enrolled Beni-Suef University Cairo University · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

We will compare between Carbitocin and Misoprostol in prevention of postpartum hemorrhage in high risk patients after C.S.

Timeline

Start
2014-10
Primary completion
2021-08
Completion
2021-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbetocin Peptide 100 ug Intravenous
Comparator Misoprostol Other / unclassified 600 ug Rectal

Indications

No indication recorded.